Top 20 pharma companies' capex to surge by 40%: CRISIL
India's top 20 pharmaceutical companies would increase capital expenditure by 40 percent to more than Rs 50,000 crore by fiscal 2018, credit rating agency CRISIL said Wednesday.
Aug 13, 2014, 20:11 PM IST
Sun Pharma-Ranbaxy deal gets BSE, NSE clearance
The combination of Sun Pharma and Ranbaxy creates the fifth-largest speciality generics company in the world and the largest pharmaceutical company in India.
Jul 21, 2014, 13:33 PM IST
Price cut: Drug makers' profitability may come under pressure
Among MNCs, Sanofi Aventis, Abbott and Pfizer are also likely to be affected owing to their sizeable share exposure on anti-diabetic segment and Indian market in general.
Jul 20, 2014, 12:42 PM IST
Indian, US generic firms launch 'Coalition for Affordable Care'
This was in order to maintain their market share and destroy competition, the Coalition for Affordable Care said in a media statement.
Jun 26, 2014, 13:28 PM IST
